Skip to main content
Top
Published in: Supportive Care in Cancer 10/2012

01-10-2012 | Original Article

Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer

Authors: Carissa Bonner, Kathryn Nattress, Caroline Anderson, Jonathan Carter, Chris Milross, Shannon Philp, Ilona Juraskova

Published in: Supportive Care in Cancer | Issue 10/2012

Login to get access

Abstract

Purpose

Pelvic radiotherapy for gynaecological cancer often leads to damage of the vaginal mucosa, resulting in stenosis (obstruction by scar tissue). Stenosis has been associated with sexual dysfunction and can hinder medical examinations to detect recurrence. The use of vaginal dilators is frequently recommended to prevent or minimise stenosis, but women are reluctant to use these devices. The aim of this study was to explore the patient experience of dilator use and identify the barriers and facilitators affecting compliance with clinician recommendations.

Methods

Women were eligible for the study if they had undergone pelvic radiotherapy for gynaecological cancer up to 2 years ago and received a vaginal dilator as part of their post-treatment rehabilitation. Fifteen participants completed a semi-structured interview.

Results

Barriers to dilator use included: uncertainty about how/when to use dilators, viewing it as a negative experience, lack of time or forgetting and the need for discretion due to an association with sex aids. Facilitators included: concern about stenosis, belief that dilators work, reminders of stenosis, acceptance of dilator use as part of their normal routine or an extension of medical treatment and focusing on positive aspects. These factors were incorporated into a model of dilator use based on the Health Belief Model.

Conclusions

This is the first qualitative study to specifically investigate the patient experience of dilator use. The barriers and facilitators identified in this study and the proposed theory-based model provide new insights to inform future research and clinical management of dilator use.
Literature
1.
go back to reference Hartman P, Diddle AW (1972) Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer 30:426–429PubMedCrossRef Hartman P, Diddle AW (1972) Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer 30:426–429PubMedCrossRef
2.
go back to reference Lancaster L (2004) Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. Eur J Oncol Nurs 8(1):30–39PubMedCrossRef Lancaster L (2004) Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. Eur J Oncol Nurs 8(1):30–39PubMedCrossRef
3.
go back to reference Jeffries SA, Robinson JW, Craighead PS, Keats MR (2006) An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 65(2):404–411PubMedCrossRef Jeffries SA, Robinson JW, Craighead PS, Keats MR (2006) An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 65(2):404–411PubMedCrossRef
4.
go back to reference Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE (1993) Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial cancer. Int J Radiat Oncol Biol Phys 27(4):825–830PubMedCrossRef Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE (1993) Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial cancer. Int J Radiat Oncol Biol Phys 27(4):825–830PubMedCrossRef
5.
go back to reference Decruze SB, Guthrie D, Magnani R (1999) Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 11:46–48CrossRef Decruze SB, Guthrie D, Magnani R (1999) Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 11:46–48CrossRef
6.
go back to reference Flay LD, Matthews JH (1995) The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys 31:399–404PubMedCrossRef Flay LD, Matthews JH (1995) The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys 31:399–404PubMedCrossRef
7.
go back to reference Schover LR, Fife M, Gershenson DM (1989) Sexual dysfunction and treatment for early stage cervical cancer. Cancer 63(1):204–212PubMedCrossRef Schover LR, Fife M, Gershenson DM (1989) Sexual dysfunction and treatment for early stage cervical cancer. Cancer 63(1):204–212PubMedCrossRef
8.
go back to reference Denton AS, Maher EJ (2003) Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database of Systematic Reviews, Issue 1 Denton AS, Maher EJ (2003) Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database of Systematic Reviews, Issue 1
9.
go back to reference Miles T, Johnson N (2010) Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database of Systematic Reviews, Issue 9 Miles T, Johnson N (2010) Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database of Systematic Reviews, Issue 9
10.
go back to reference White ID, Faithfull S (2006) Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. Int J Gynecol Cancer 16:1140–1146PubMedCrossRef White ID, Faithfull S (2006) Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. Int J Gynecol Cancer 16:1140–1146PubMedCrossRef
11.
go back to reference Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker NF (2003) Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psycho-Oncol 12:267–279CrossRef Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker NF (2003) Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psycho-Oncol 12:267–279CrossRef
12.
go back to reference Krumm S, Lamberti J (1993) Changes in sexual behaviour following radiation therapy for cervical cancer. J Psychosom Obstet Gynaecol 14(1):51–63PubMedCrossRef Krumm S, Lamberti J (1993) Changes in sexual behaviour following radiation therapy for cervical cancer. J Psychosom Obstet Gynaecol 14(1):51–63PubMedCrossRef
13.
go back to reference Robinson JW, Faris PD, Scott CB (1999) Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 44(3):497–506PubMedCrossRef Robinson JW, Faris PD, Scott CB (1999) Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 44(3):497–506PubMedCrossRef
14.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370PubMedCrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370PubMedCrossRef
15.
go back to reference Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101CrossRef Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101CrossRef
16.
go back to reference Rosenstock I (1974) The Health Belief Model and preventive health behaviour. In: The Health Belief Model and personal health behaviour. M. Becker (ed). Thorofare: Charles B Slack. 27–59 Rosenstock I (1974) The Health Belief Model and preventive health behaviour. In: The Health Belief Model and personal health behaviour. M. Becker (ed). Thorofare: Charles B Slack. 27–59
17.
Metadata
Title
Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer
Authors
Carissa Bonner
Kathryn Nattress
Caroline Anderson
Jonathan Carter
Chris Milross
Shannon Philp
Ilona Juraskova
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 10/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1337-z

Other articles of this Issue 10/2012

Supportive Care in Cancer 10/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine